Business
Harbour BioMed and BioMap launch AI-native pipeline company for complex biologics discovery
Harbour BioMed (HKEX: 02142) and AI life sciences company BioMap have jointly announced the formation of MegaStream TechBio, a newly created AI-native...
HMNC Brain Health secures USD 50 million to advance dual depression programs toward Phase III
Germany-based HMNC Brain Health (HMNC Holding GmbH) has closed a USD 50 million first closing of its Series B financing round, paired with a strategic...
Human Continuum raises USD 5m in seed funding for exosome-based longevity platform
Jupiter, Florida-based Human Continuum Inc. has closed a USD 5.13 million seed financing round to advance its exosome-based therapeutics and diagnostics...
Enliven Therapeutics upsizes USD 400m offering to 60% above target
Burlingame, California-based Enliven Therapeutics, Inc. (Nasdaq: ELVN) announced the pricing of an upsized underwritten public offering of common stock and...
Otsuka completes USD 1.2b acquisition of Transcend Therapeutics for PTSD neuroplastogen
Otsuka Pharmaceutical has completed its acquisition of Transcend Therapeutics, with New York-based Transcend now a wholly owned subsidiary of Otsuka...
Adial Pharma buys out Stanford Uni spinout Azora, holds USD 64m financing round
Glen Allen, Virginia-based Adial Pharmaceuticals (Nasdaq: ADIL) has acquired Azora Therapeutics, a Stanford University spinout developing oral...
Summit thinks twice about USD 200m public offering citing adverse market conditions
Summit Therapeutics Inc. (Nasdaq: SMMT) disclosed on June 12, 2026 that it had withdrawn a previously announced proposed underwritten public offering,...
Kardigan goes public to raise USD 373m with pipeline of cardiac myosin inhibitors
Kardigan, Inc. (Nasdaq: KARD), a Princeton, New Jersey-based clinical-stage cardiovascular therapeutics company led by the founders of MyoKardia, filed...
Chiesi completes USD 1.9b acquisition of KalVista for rare disease expansion
Italy-based Chiesi Group has completed its acquisition of Framingham, Massachusetts-based KalVista Pharmaceuticals (Nasdaq: KALV) for USD 27.00 per share in...
Neion Bio raises USD 23m Series A to scale egg-based bio-manufacturing
New York-based Neion Bio, Inc., a biotechnology company developing a genetic engineering-based platform for biologics manufacturing, has closed an...
Atossa raises USD 16.5m via direct offering to extend (Z)-endoxifen development runway
Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS) announced a registered direct offering of up to USD 16.5 million in total potential gross proceeds,...
Kuva Labs begins tender offer to buy out Lisata for RGD peptide cancer drug
Houston-based Kuva Labs Inc. has commenced a tender offer to acquire all outstanding shares of Liberty Corner, New Jersey-based Lisata Therapeutics, Inc....
BridgeBio partners with DKSH to distribute acoramidis across four Asia Pacific markets
BridgeBio's acoramidis finds a distribution partner for four Asia Pacific markets, as the oral TTR stabilizer pursues regulatory approvals in geographies...
Teva closes purchase of Emalex in USD 900m deal for neuroscience pipeline
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has closed its acquisition of Emalex Biosciences for USD 700 million upfront, with up to USD 200...
Cordex Biologics grants Medexus Pharmaceuticals exclusive Canadian rights for Zemcelpro cell therapy
Riding its European approval, ExCellThera's Montreal-based subsidiary Cordex Biologics has signed exclusive licensing and supply agreements granting Medexus...
The AllSci Brief
Systematic R&D and deal news. Daily.